These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 12186629

  • 1. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
    Latsis T, Andersen B, Agius L.
    Biochem J; 2002 Nov 15; 368(Pt 1):309-16. PubMed ID: 12186629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.
    Andersen B, Rassov A, Westergaard N, Lundgren K.
    Biochem J; 1999 Sep 15; 342 Pt 3(Pt 3):545-50. PubMed ID: 10477265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.
    Aiston S, Green A, Mukhtar M, Agius L.
    Biochem J; 2004 Jan 01; 377(Pt 1):195-204. PubMed ID: 13678417
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased potency and efficacy of combined phosphorylase inactivation and glucokinase activation in control of hepatocyte glycogen metabolism.
    Hampson LJ, Agius L.
    Diabetes; 2005 Mar 01; 54(3):617-23. PubMed ID: 15734835
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory properties of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) derivatives acting on glycogen metabolising enzymes.
    Díaz-Lobo M, Concia AL, Gómez L, Clapés P, Fita I, Guinovart JJ, Ferrer JC.
    Org Biomol Chem; 2016 Sep 26; 14(38):9105-9113. PubMed ID: 27714243
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of glycogen phosphorylase activity affects 5-phosphoribosyl-1-pyrophosphate availability in rat hepatocyte cultures.
    Boer P, Sperling O.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 26; 23(8-9):1235-9. PubMed ID: 15571236
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors.
    Ercan-Fang N, Taylor MR, Treadway JL, Levy CB, Genereux PE, Gibbs EM, Rath VL, Kwon Y, Gannon MC, Nuttall FQ.
    Am J Physiol Endocrinol Metab; 2005 Sep 26; 289(3):E366-72. PubMed ID: 15797986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of glycogen phosphorylase stimulates ventromedial hypothalamic nucleus AMP-activated protein kinase: Activity and neuronal nitric oxide synthase protein expression in male rats.
    Alhamami HN, Alshamrani A, Briski KP.
    Physiol Rep; 2017 Dec 26; 5(23):. PubMed ID: 29199177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis.
    Aiston S, Coghlan MP, Agius L.
    Eur J Biochem; 2003 Jul 26; 270(13):2773-81. PubMed ID: 12823547
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
    Mackay P, Ynddal L, Andersen JV, McCormack JG.
    Diabetes Obes Metab; 2003 Nov 26; 5(6):397-407. PubMed ID: 14617225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.